glial cell & antennal disc, with Scer\GAL4hs.PB
larval optic lobe & glial cell | somatic clone | cell non-autonomous, with Scer\GAL4αTub84B.PP
medulla cortex & glial cell | somatic clone | cell non-autonomous, with Scer\GAL4αTub84B.PP
photoreceptor cell & axon & eye disc, with Scer\GAL4bi-omb-Gal4
sensory neuron & axon & embryo, with Scer\GAL4repo
subretinal glial cell & eye disc, with Scer\GAL4bi-omb-Gal4
subretinal glial cell & larval optic stalk, with Scer\GAL4bi-omb-Gal4
Expressing Ras85DN17.UAS under the control of Scer\GAL4Bx-MS1096 results in a reduced wing size and loss of vein material.
Expression of Ras85DN17.UAS under the control of Scer\GAL4Su(H).GBE (in combination with tub-Gal80[ts] to restrict expression to the adult stage) leads to a decrease in the cell size of enteroblasts in adult guts when compared to controls.
Expression of Ras85DN17.Scer\UAS specifically in adult glia (under the control of Scer\GAL4repo and Scer\GAL80ts.αTub84B) generates a mild glial engulfment phenotype, resulting in a slight delay in phagocytosis of axonal debris after axotomy.
Expression of Ras85DN17.Scer\UAS under the control of Scer\GAL4esg-NP5130 and Scer\GAL80ts.αTub84B has a mild reducing effect on intestinal stem cells/epithelial enteroblasts cell numbers.
Subperineurial expression of Ras85DN17.Scer\UAS under the control of Scer\GAL4Gli-rL82 in a wild-type genetic background has only a minor effect on larval peripheral nerves.
Increased gut length is observed in flies expressing Ras85DN17.Scer\UAS under the control of Scer\GAL4Myo31DF-NP0001.
Guts of flies expressing Ras85DN17.Scer\UAS in enterocytes under the control of Scer\GAL4Myo31DF-NP0001 and Scer\GAL80ts.αTub84B shrink less upon infection with Erwinia carotovora carotovora 15 (Ecc15). After a recovery phase of 2 or 8 days, the guts are 25% longer than their wild-type counterparts.
Expression of Ras85DN17.Scer\UAS under the control of Scer\GAL4bi.PU results in the loss of the central part of wing vein L4.
Expression of Ras85DN17.Scer\UAS in the larvae under the control of Scer\GAL4Act5C.Switch.PR does not result in lethality. Both male and female life-span not reduced significantly when Ras85DV12.Scer\UAS is expressed in adult flies.
Expression of Ras85DN17.Scer\UAS in the wing blade using Scer\GAL4MD-638 results in loss of sections of wing vein.
The number of fusion competent myoblasts is increased in stage 11 embryos that express Ras85DV12.Scer\UAS under the control of Scer\GAL4twi.PB.
Expression of Ras85DN17.Scer\UAS under the control of Scer\GAL4btl.PS results tracheal branching defects in embryos.
There is a large increase in primordial germ cell numbers when the dominant negative Ras85DN17.Scer\UAS is expressed in somatic gonadal cells by Scer\GAL4C587.
Expression of Ras85DN17.Scer\UAS, under the control of Scer\GAL4en-e16E, in the posterior compartment cells of embryos results in apoptosis of these cells, beginning at stage 12. The increased apoptosis occurs mainly at the front of the posterior compartment. Overall compartment size is reduced. Surviving cells are larger than normal.
Expression of Ras85DN17.Scer\UAS under the control of Scer\GAL4amn-c651, results in pupae and adults that are larger than wild-type controls. These flies also undergo delayed pupariation about 48 hr after wild-type controls, which is mostly due to a prolonged second-instar stage. Expression of Ras85DN17.Scer\UAS under the control of Scer\GAL4amn-X8 causes an increase in pupal length. Expression of Ras85DN17.Scer\UAS under the control of Scer\GAL4amn-c651 has no effect on prothoracic gland cell size.
Hemocytes are mildly enlarged in about one third of Ras85DN17.Scer\UAS; Scer\GAL4srp.Hemo embryos.
Somatic clones of Ras85DN17.Scer\UAS; Scer\GAL4αTub84B.PP neurons in the posterior of the optic lobe result in failure of scaffold axons to extend toward glial destinations. When the scaffold axons are absent, glia stall prior to migrating into the neuropile regions. The number of apoptotic cells is increased in the cortical areas next to the resulting glia-deficient regions.
Migration of ganglionic tracheal branches is abberant in Ras85DN17.Scer\UAS; Scer\GAL4bs-23.26 embryos. Migration of around half of these branches stalls outside the ventral nerve cord. A smaller proportion are grossly misrouted (8%) or cross the midline (4%).
Flies expressing Ras85DN17.Scer\UAS under the control of Scer\GAL4GMR.PU have reduced and roughened eyes.
When Ras85DN17.Scer\UAS is driven by Scer\GAL4hs.PB and heatshocked between 14 and 15 hours after puparium formation, a severe reduction is seen in numbers of antennal glia.
Ras85DN17.Scer\UAS; Scer\GAL4prd.RG1 embryos do not have obvious cuticle phenotypes.
Ras85DN17.Scer\UAS with Scer\GAL4pnr-MD237 or Scer\GAL4426 does not affect wing disc development. Ras85DN17.Scer\UAS with Scer\GAL4ap-md544 or Scer\GAL4tsh-md621 causes severe reduction in notum tissue in the 3rd instar wing disc; however, no transformation of notum to wing fate is observed in these discs. Ras85DN17.Scer\UAS with Scer\GAL4Gug-AGiR causes reduction in notum tissue in the 3rd instar wing disc. Ras85DN17.Scer\UAS; Scer\GAL4Ubx-lac1-Gal4 adults exhibit wing duplication in the posterior compartment and partial loss of notum and/or hinge. Occasionally pharate adults die within the pupal case, with severe loss of notum tissue. In larvae of this genotype, the wing discs show altered morphology, particularly overgrowth in the posterior hinge and mesonotum. Marker analysis indicates formation a new wing pouch complete with the DV boundary, and that pattern duplication is associated with loss of notum, confirming notum/hinge-to-wing transformations. Ras85DN17.Scer\UAS; Scer\GAL4ap-md544 third instar wing discs show a severe reduction in the notum size.
Expression of Ras85DN17.Scer\UAS in embryonic glia, under the control of Scer\GAL4repo, causes PNS patterning defects in hemisegments. Embryos show incomplete peripheral glial ensheathment of nerves and stalled glia that are able to extend cytoplasmic processes, although to a lesser extent than in wild type. In hemisegments that are moderately affected, sensory axons can be misdirected and nerves in the CNS-PNS transition zone show incorrect fasciculation-bundling. In severely-affected hemisegments, there is a loss of sensory neurons and those remaining have misplaced cell bodies and misdirected sensory axons. Additionally, motor neuron patterning is disrupted.
Hemocytes in mutant embryos (Ras85DN17.Scer\UAS driven by Scer\GAL4gcm.PP) fail to enter the tail.
When Ras85DN17.Scer\UAS is driven by Scer\GAL4ftz.ng, no midline crossovers are seen in the pCC/MP2 pathway axons. When Ras85DN17.Scer\UAS is driven by Scer\GAL4ftz.ng, only 2% of embryos exhibit midline crossovers are seen in the pCC/MP2 pathway axons.
Expression of Ras85DN17.Scer\UAS driven by Scer\GAL4332.3 does not affect either the dorsal cuticle or amnioserosa morphology.
Expression of Ras85DN17.Scer\UAS, under the control of Scer\GAL4C380 increases the number of type I synaptic boutons compared to wild-type controls. This increase is indistinguishable from the increase in bouton number observed in flies where Ras85DScer\UAS.cKa expression is driven by Scer\GAL4C380.
Expression of Ras85DN17.Scer\UAS under the control of Scer\GAL4slbo.2.6 moderately affects posterior and dorsal border cell migration.
Ras85DN17.Scer\UAS; P{sgcm-GAL4}151 embryos exhibit a dramatic increase in apoptosis of longitudinal (interface) glial cells.
Expression of Ras85DN17.Scer\UAS under the control of Scer\GAL4dpp.blk1 inhibits furrow reincarnation along the lateral margins, but not furrow birth at the posterior of the eye disc.
Imaginal disc cells expressing Ras85DN17.Scer\UAS under the control of Scer\GAL4Act5C.PP are smaller than wild-type cells. The cells have longer apparent doubling times. The cells mix well with neighbouring wild-type cells. Pyknotic nuclei, indicating cell autonomous cell death, are seen. The proportion of cells in G1 is increased and the proportion of cells in S phase is decreased. Clones expressing Ras85DN17.Scer\UAS under the control of Scer\GAL4Act5C.PP fails to make veins in adult wings.
Expression of Ras85DN17.Scer\UAS under the control of Scer\GAL4hs.PB (using heat shock) results in many first instar larvae with mild puckering of the dorsal cuticle.
The anterior crossvein is missing in flies expressing Ras85DN17.Scer\UAS under the control of Scer\GAL4dpp.blk1.
Expression of Ras85DN17.Scer\UAS under the control of Scer\GAL448Y in the developing midgut has no effect on the migration of the endodermal midgut cells.
The number of glial cells in the optic stalk is reduced and they fail to migrate into the eye disc in approximately 10% of eye discs expressing Ras85DN17.Scer\UAS under the control of Scer\GAL4bi-omb-Gal4. In these cases the photoreceptor cells are able to grow axons and these axons orient their growth towards the posterior of the eye disc as in wild type. However, the axons then remain stuck in the eye disc and are unable to exit into the optic stalk. In 40% of cases, eye discs expressing Ras85DN17.Scer\UAS under the control of Scer\GAL4bi-omb-Gal4 contain a small number of glial cells (3 to 20). These glial cells are found very close to the optic stalk at the very posterior end of the eye disc where they remain in a cluster. The cell bodies of the glial cells are small and do not extend much anteriorly. Axons are able to exit into the optic stalk normally in these eye discs.
Scer\GAL4sli.PS-mediated expression in wild type embryos does not result in an abnormal CNS phenotype. Scer\GAL4sim.PS-mediated expression in Ras85D deficient embryos causes slight fusion of commissures.
The presence of Scer\GAL4c306 causes a mild delay in the migration of border cells in egg chambers. Border cell phenotype is enhanced in Scer\GAL4c306; P{UAS-Ras85D.N17}; Ras85DΔ17b/Ras85D+ flies.
Ras85DN17.UAS has visible phenotype, enhanceable by dgt2HM04038/Scer\GAL4Bx-MS1096
Ras85DN17.UAS has visible phenotype, enhanceable by CtpsHM04062/Scer\GAL4Bx-MS1096
Ras85DN17.UAS has visible phenotype, enhanceable by Scer\GAL4Bx-MS1096/CG6984HM04063
Ras85DN17.UAS has visible phenotype, enhanceable by Scer\GAL4Bx-MS1096/agoHM04005
Ras85DN17.UAS has visible phenotype, enhanceable by IntS3HM04039/Scer\GAL4Bx-MS1096
Ras85DN17.UAS has visible phenotype, enhanceable by Tep4GD5530/Scer\GAL4Bx-MS1096
Ras85DN17.UAS has visible phenotype, enhanceable by Tep4KK106228/Scer\GAL4Bx-MS1096
Ras85DN17.UAS has visible phenotype, enhanceable by Elp4RNAi.UAS.WIZ/Scer\GAL4Bx-MS1096
Ras85DN17.UAS, Scer\GAL4bi.PU has visible phenotype, enhanceable by Bap170C1.UAS, Scer\GAL4bi.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, enhanceable by grpEP587, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, enhanceable by bchsEP2299, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by MESR4EP386, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by Akap200EP2072, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by C3GUAS.Tag:MYC, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by cindrEP3700, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by pblEP3415, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by hppyEP2445, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by SNF4AγEP648, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by P{EP}EP2491, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by kisEP563, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by domEP2371, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by Dp1EP2422, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by poeEP349, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by poeEP737, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by P{EP}faxEP807, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by cdiEP3319, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by Traf6EP325, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by P{EP}wunEP652, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by rho-6EP2023, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by CG6701EP2054, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by P{EP}EP2233, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by numbEP2455, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by cpoEP3395, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by Gtpbp2EP3503, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by RhoGEF64CEP3035, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by RhoGEF64CEP3322, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by DlatEP816, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4Bx-MS1096 has abnormal size | adult stage phenotype, suppressible by rlD334N.UAS.cKa, Scer\GAL4Bx-MS1096
Ras85DN17.UAS, Scer\GAL4Bx-MS1096 has abnormal size | adult stage phenotype, suppressible by rlR80S.D334N.UAS, Scer\GAL4Bx-MS1096
Ras85DN17.UAS, Scer\GAL4Bx-MS1096 has abnormal size | adult stage phenotype, suppressible by rlR80S.UAS, Scer\GAL4Bx-MS1096
Ras85DN17.UAS, Scer\GAL4Bx-MS1096 has visible | adult stage phenotype, suppressible by rlR80S.UAS, Scer\GAL4Bx-MS1096
Ras85DN17.UAS, Scer\GAL4Bx-MS1096 has visible | adult stage phenotype, suppressible by rlD334N.UAS.cKa, Scer\GAL4Bx-MS1096
Ras85DN17.UAS, Scer\GAL4Bx-MS1096 has visible | adult stage phenotype, suppressible by rlR80S.D334N.UAS, Scer\GAL4Bx-MS1096
Ras85DN17.UAS, Scer\GAL4Su(H).GBE has decreased cell size | adult stage phenotype, suppressible by zfh2EAB, Scer\GAL4Su(H).GBE
Ras85DN17.UAS, Scer\GAL4Switch1.106 has long lived | RU486 conditional phenotype, suppressible by aopHMS01256, Scer\GAL4Switch1.106
Ras85DN17.UAS has visible phenotype, suppressible by Spn42DcHM04068/Scer\GAL4Bx-MS1096
Ras85DN17.UAS has visible phenotype, suppressible by dcoUAS.Tag:HA/Scer\GAL4Bx-MS1096
Ras85DN17.UAS has visible phenotype, suppressible by fzyHM04081/Scer\GAL4Bx-MS1096
Ras85DN17.UAS has visible phenotype, suppressible by CoRestHM04053/Scer\GAL4Bx-MS1096
Ras85DN17.UAS has visible phenotype, suppressible by Vps4HM04061/Scer\GAL4Bx-MS1096
Ras85DN17.UAS has visible phenotype, suppressible by Scer\GAL4Bx-MS1096/uriHM04028
Ras85DN17.UAS, Scer\GAL4Act5C.PP has increased cell death | somatic clone | cell autonomous | larval stage phenotype, suppressible by BacA\p35UAS.cHa, Scer\GAL4Act5C.PP
Ras85DN17.UAS, Scer\GAL4Act5C.PP has decreased occurrence of cell division | somatic clone | cell autonomous | larval stage phenotype, suppressible | partially by BacA\p35UAS.cHa, Scer\GAL4Act5C.PP
Ras85DN17.UAS, Scer\GAL4Act5C.PP has decreased occurrence of cell division | somatic clone | cell autonomous | larval stage phenotype, suppressible by MycUAS.cZa, Scer\GAL4Act5C.PP
Ras85DN17.UAS, Scer\GAL4Bx-MS1096 has abnormal size | adult stage phenotype, non-suppressible by rlWT.UAS, Scer\GAL4Bx-MS1096
Ras85DN17.UAS, Scer\GAL4Bx-MS1096 has visible | adult stage phenotype, non-suppressible by rlWT.UAS, Scer\GAL4Bx-MS1096
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by MESR4EP386, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by Akap200EP2072, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by C3GUAS.Tag:MYC, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by cindrEP3700, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by pblEP3415, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by RhoGEF64CEP3035, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by RhoGEF64CEP3322, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by hppyEP2445, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by SNF4AγEP648, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by P{EP}EP2491, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by kisEP563, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by domEP2371, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by Dp1EP2422, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by poeEP349, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by poeEP737, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by P{EP}faxEP807, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by cdiEP3319, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by Traf6EP325, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by P{EP}wunEP652, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by DlatEP816, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by rho-6EP2023, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by CG6701EP2054, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by P{EP}EP2233, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by numbEP2455, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by cpoEP3395, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by Gtpbp2EP3503, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4Su(H).GBE is a non-enhancer of abnormal cell shape | adult stage phenotype of Scer\GAL4Su(H).GBE, zfh2EAB
Ras85DN17.UAS, Scer\GAL4GMR.PU is a non-enhancer of visible | adult stage phenotype of HPV18\E6UAS.Tag:MYC, Hsap\UBE3AUAS.cRa, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4Switch1.106 is a non-enhancer of long lived | RU486 conditional phenotype of Scer\GAL4Switch1.106, aopACT.UAS
Ras85DN17.UAS, Scer\GAL4Su(H).GBE is a suppressor of increased cell size | adult stage phenotype of Scer\GAL4Su(H).GBE, zfh2EAB
Scer\GAL4unspecified/Ras85DN17.UAS is a suppressor of abnormal neuroanatomy | larval stage phenotype of SERCAKum170, comt6
Scer\GAL4unspecified/Ras85DN17.UAS is a suppressor of abnormal neurophysiology | larval stage phenotype of SERCAKum170, comt6
Ras85DN17.UAS, Scer\GAL4repo.PU is a suppressor of abnormal neuroanatomy | third instar larval stage phenotype of Pi3K92EUAS.Tag:MYC,Tag:PM(hKRAS), Scer\GAL4repo.PU, btl::Egfrλ.UAS
Ras85DN17.UAS, Scer\GAL4repo.PU is a suppressor of neoplasia | third instar larval stage phenotype of Pi3K92EUAS.Tag:MYC,Tag:PM(hKRAS), Scer\GAL4repo.PU, btl::Egfrλ.UAS
Ras85DN17.UAS, Scer\GAL4Tub.PU is a suppressor of visible phenotype of Scer\GAL4Tub.PU, cswN308D.UASp
Ras85DN17.UAS, Scer\GAL4Su(H).GBE is a non-suppressor of abnormal cell shape | adult stage phenotype of Scer\GAL4Su(H).GBE, zfh2EAB
Ras85DN17.UAS, Scer\GAL4Switch1.106 is a non-suppressor of long lived | RU486 conditional phenotype of Scer\GAL4Switch1.106, aopACT.UAS
Ras85DN17.UAS, Scer\GAL4Bx-MS1096, rlR80S.D334N.UAS has visible | adult stage phenotype
Ras85DN17.UAS, Scer\GAL4Bx-MS1096, rlD334N.UAS.cKa has visible | adult stage phenotype
Ras85DN17.UAS has wing vein phenotype, enhanceable by CtpsHM04062/Scer\GAL4Bx-MS1096
Ras85DN17.UAS has wing vein phenotype, enhanceable by Scer\GAL4Bx-MS1096/CG6984HM04063
Ras85DN17.UAS has wing vein phenotype, enhanceable by Scer\GAL4Bx-MS1096/agoHM04005
Ras85DN17.UAS has wing vein phenotype, enhanceable by IntS3HM04039/Scer\GAL4Bx-MS1096
Ras85DN17.UAS has wing vein phenotype, enhanceable by Tep4GD5530/Scer\GAL4Bx-MS1096
Ras85DN17.UAS has wing vein phenotype, enhanceable by Tep4KK106228/Scer\GAL4Bx-MS1096
Ras85DN17.UAS has wing vein phenotype, enhanceable by Elp4RNAi.UAS.WIZ/Scer\GAL4Bx-MS1096
Ras85DN17.UAS has wing vein phenotype, enhanceable by dgt2HM04038/Scer\GAL4Bx-MS1096
Ras85DN17.UAS, Scer\GAL4bi.PU has wing vein L4 phenotype, enhanceable by Bap170C1.UAS, Scer\GAL4bi.PU
Ras85DN17.UAS, Scer\GAL4MD-638 has wing vein phenotype, enhanceable by osa[+]/osa308
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, enhanceable by grpEP587, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, enhanceable by bchsEP2299, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by MESR4EP386, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by Akap200EP2072, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by C3GUAS.Tag:MYC, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by cindrEP3700, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by pblEP3415, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by hppyEP2445, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by SNF4AγEP648, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by P{EP}EP2491, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by kisEP563, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by domEP2371, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by Dp1EP2422, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by poeEP349, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by poeEP737, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by P{EP}faxEP807, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by cdiEP3319, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by Traf6EP325, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by P{EP}wunEP652, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by rho-6EP2023, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by CG6701EP2054, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by P{EP}EP2233, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by numbEP2455, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by cpoEP3395, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by Gtpbp2EP3503, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by RhoGEF64CEP3035, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by RhoGEF64CEP3322, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by DlatEP816, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4Bx-MS1096 has wing phenotype, suppressible by rlR80S.UAS, Scer\GAL4Bx-MS1096
Ras85DN17.UAS, Scer\GAL4Bx-MS1096 has wing vein phenotype, suppressible by rlR80S.UAS, Scer\GAL4Bx-MS1096
Ras85DN17.UAS, Scer\GAL4Bx-MS1096 has wing phenotype, suppressible by rlR80S.D334N.UAS, Scer\GAL4Bx-MS1096
Ras85DN17.UAS, Scer\GAL4Bx-MS1096 has wing phenotype, suppressible by rlD334N.UAS.cKa, Scer\GAL4Bx-MS1096
Ras85DN17.UAS, Scer\GAL4Bx-MS1096 has wing vein phenotype, suppressible by rlR80S.D334N.UAS, Scer\GAL4Bx-MS1096
Ras85DN17.UAS, Scer\GAL4Bx-MS1096 has wing vein phenotype, suppressible by rlD334N.UAS.cKa, Scer\GAL4Bx-MS1096
Ras85DN17.UAS, Scer\GAL4Su(H).GBE has enteroblast | adult stage phenotype, suppressible by zfh2EAB, Scer\GAL4Su(H).GBE
Ras85DN17.UAS, Scer\GAL4Su(H).GBE has adult gut phenotype, suppressible by zfh2EAB, Scer\GAL4Su(H).GBE
Ras85DN17.UAS has wing vein phenotype, suppressible by Spn42DcHM04068/Scer\GAL4Bx-MS1096
Ras85DN17.UAS has wing vein phenotype, suppressible by dcoUAS.Tag:HA/Scer\GAL4Bx-MS1096
Ras85DN17.UAS has wing vein phenotype, suppressible by fzyHM04081/Scer\GAL4Bx-MS1096
Ras85DN17.UAS has wing vein phenotype, suppressible by CoRestHM04053/Scer\GAL4Bx-MS1096
Ras85DN17.UAS has wing vein phenotype, suppressible by Vps4HM04061/Scer\GAL4Bx-MS1096
Ras85DN17.UAS has wing vein phenotype, suppressible by Scer\GAL4Bx-MS1096/uriHM04028
Ras85DN17.UAS, Scer\GAL4ap-md544 has wing disc phenotype, suppressible | partially by BacA\p35UAS.cHa, Scer\GAL4ap-md544
Ras85DN17.UAS, Scer\GAL4Act5C.PP has imaginal disc | somatic clone phenotype, suppressible | partially | somatic clone by BacA\p35UAS.cHa, Scer\GAL4Act5C.PP
Ras85DN17.UAS, Scer\GAL4Act5C.PP has mitotic cell cycle | somatic clone phenotype, suppressible by MycUAS.cZa, Scer\GAL4Act5C.PP
Ras85DN17.UAS, Scer\GAL4Bx-MS1096 has wing phenotype, non-suppressible by rlWT.UAS, Scer\GAL4Bx-MS1096
Ras85DN17.UAS, Scer\GAL4Bx-MS1096 has wing vein phenotype, non-suppressible by rlWT.UAS, Scer\GAL4Bx-MS1096
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by MESR4EP386, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by Akap200EP2072, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by kisEP563, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by domEP2371, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by Dp1EP2422, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by poeEP349, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by poeEP737, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by P{EP}faxEP807, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by cdiEP3319, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by Traf6EP325, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by P{EP}wunEP652, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by DlatEP816, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by C3GUAS.Tag:MYC, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by rho-6EP2023, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by CG6701EP2054, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by P{EP}EP2233, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by numbEP2455, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by cpoEP3395, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by Gtpbp2EP3503, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by cindrEP3700, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by pblEP3415, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by RhoGEF64CEP3035, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by RhoGEF64CEP3322, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by hppyEP2445, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by SNF4AγEP648, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by P{EP}EP2491, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4Su(H).GBE is a non-enhancer of enteroblast | adult stage phenotype of Scer\GAL4Su(H).GBE, zfh2EAB
Ras85DN17.UAS, Scer\GAL4Su(H).GBE is a non-enhancer of adult gut phenotype of Scer\GAL4Su(H).GBE, zfh2EAB
Ras85DN17.UAS, Scer\GAL4Su(H).GBE is a non-enhancer of plasma membrane | adult stage phenotype of Scer\GAL4Su(H).GBE, zfh2EAB
Ras85DN17.UAS, Scer\GAL4GMR.PU is a non-enhancer of eye phenotype of HPV18\E6UAS.Tag:MYC, Hsap\UBE3AUAS.cRa, Scer\GAL4GMR.PU
Ras85DN17.UAS, Scer\GAL4NP5130 is a suppressor of adult midgut phenotype of PvrCA.UAS, Scer\GAL4NP5130
Scer\GAL4unspecified/Ras85DN17.UAS is a suppressor of neuromuscular junction | larval stage phenotype of SERCAKum170, comt6
Ras85DN17.UAS, Scer\GAL4repo.PU is a suppressor of glial cell | increased number | third instar larval stage phenotype of Pi3K92EUAS.Tag:MYC,Tag:PM(hKRAS), Scer\GAL4repo.PU, btl::Egfrλ.UAS
Ras85DN17.UAS, Scer\GAL4repo.PU is a suppressor of embryonic/larval brain | third instar larval stage phenotype of Pi3K92EUAS.Tag:MYC,Tag:PM(hKRAS), Scer\GAL4repo.PU, btl::Egfrλ.UAS
Ras85DN17.UAS, Scer\GAL4Tub.PU is a suppressor of wing vein | ectopic phenotype of Scer\GAL4Tub.PU, cswN308D.UASp
Ras85DN17.UAS, Scer\GAL4Su(H).GBE is a non-suppressor of enteroblast | adult stage phenotype of Scer\GAL4Su(H).GBE, zfh2EAB
Ras85DN17.UAS, Scer\GAL4Su(H).GBE is a non-suppressor of adult gut phenotype of Scer\GAL4Su(H).GBE, zfh2EAB
Ras85DN17.UAS, Scer\GAL4Su(H).GBE is a non-suppressor of plasma membrane | adult stage phenotype of Scer\GAL4Su(H).GBE, zfh2EAB
Ras85DN17.UAS, Scer\GAL4Bx-MS1096, rlD334N.UAS.cKa has wing phenotype
Ras85DN17.UAS, Scer\GAL4Bx-MS1096, rlD334N.UAS.cKa has wing vein | ectopic phenotype
Ras85DN17.UAS, Scer\GAL4Bx-MS1096, rlD334N.UAS.cKa has wing vein phenotype
Ras85DN17.UAS, Scer\GAL4Bx-MS1096, rlR80S.D334N.UAS has wing phenotype
Ras85DN17.UAS, Scer\GAL4Bx-MS1096, rlR80S.D334N.UAS has wing vein | ectopic phenotype
Ras85DN17.UAS, Scer\GAL4Bx-MS1096, rlR80S.D334N.UAS has wing vein phenotype
Bap170C1.UAS, Ras85DN17.UAS, Scer\GAL4bi.PU has wing margin phenotype
Bap170C1.UAS, Ras85DN17.UAS, Scer\GAL4bi.PU has wing vein L3 | distal phenotype
Bap170C1.UAS, Ras85DN17.UAS, Scer\GAL4bi.PU has wing blade phenotype
The wing defects induced by the expression of Ras85DN17.UAS under the control of Scer\GAL4Bx-MS1096 (smaller wing and loss of L3-5 vein material are: fully suppressed by the co-expression of either rlD334N.UAS.cKa or rlR80S.D334N.UAS, even leading to extra vein material (more severe in the latter, with darker pigmentation); partially suppressed by the co-expression of rlR80S.UAS (complete suppression in L3, partial suppression in L4 or L5); not suppressed by the co-expression of rlWT.UAS.
Co-expression of Ras85DN17.Scer\UAS and PvrCA.Scer\UAS under the control of Scer\GAL4esg-NP5130 and Scer\GAL80ts.αTub84B significantly abrogates the PvrCA.Scer\UAS dysplastic phenotype, indicating that Ras85D is a downstream signaling component in the Pvr-dependent regulation of intestinal homeostasis.
Expression of Ras85DN17.Scer\UAS in motor neurons under the control of Scer\GAL4unspecified suppresses the increased synaptic growth and transmitter release observed at the neuromuscular junction in comt6 Ca-P60AKum170 larvae.
Co-expression of Bap170C1.Scer\UAS enhances the loss of wing vein L4 that is seen in flies expressing Ras85DN17.Scer\UAS under the control of Scer\GAL4bi.PU, such that there is a loss of the entire L4 vein distal to the posterior crossvein. The distal end of wing vein L3 is missing in these flies and a reduction in wing surface area and occasional notching of the wing margin is also seen.
Expression of Ras85DN17.Scer\UAS moderately suppresses the glial neoplasia seen in third instar larvae when btl::EgfrScer\UAS.T:λ\cI-DD and Pi3K92EScer\UAS.T:Hsap\MYC,T:Hsap\CAAX are co-expressed under the control of Scer\GAL4repo.PU.
The loss of wing vein by overexpression of Ras85DN17.Scer\UAS under the control of Scer\GAL4MD-638 is enhanced by osa308/+.
Denticle belt fusions in the cuticles of rho7M43; ru1 double homozygous embryos are enhanced by Ras85DN17.Scer\UAS; Scer\GAL4prd.RG1.
The reduction in notum size seen in the wing discs of Ras85DN17.Scer\UAS; Scer\GAL4ap-md544 third instar larvae is partially suppressed by BacA\p35Scer\UAS.cHa.
Co-expressing BacA\p35Scer\UAS.cHa with Ras85DN17.Scer\UAS under the control of Scer\GAL4Act5C.PP completely suppresses the Ras85DN17.Scer\UAS cell death phenotype and increases the number of cells per clone. The doubling time defect is only partially rescued. 40 hours after induction, clones in imaginal discs co-expressing Ras85DN17.Scer\UAS and BacA\p35Scer\UAS.cHa under the control of Scer\GAL4Act5C.PP are 23% smaller than clones expressing BacA\p35Scer\UAS.cHa alone under the control of Scer\GAL4Act5C.PP. Clones expressing both dmScer\UAS.cZa and Ras85DN17.Scer\UAS under the control of Scer\GAL4Act5C.PP in clones in the imaginal discs have a similar cell size and cell cycle profiles as those of cells expressing dmScer\UAS.cZa alone under the control of Scer\GAL4Act5C.PP. The elongated doubling time of cells expressing Ras85DN17.Scer\UAS under the control of Scer\GAL4Act5C.PP is partially rescued by co-expression of dmScer\UAS.cZa.
The additional co-expression of Ras85DN17.Scer\UAS does not modify the fully penetrant rough eye phenotype resulting from the co-expression of HPV18\E6Scer\UAS.T:Hsap\MYC and Hsap\UBE3AScer\UAS.cRa under the control of Scer\GAL4GMR.PU.